Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Bayer AG | 2,187 |
| 2 | Novo Nordisk Fonden | 552 |
| 3 | Bristol Myers Squibb Co | 367 |
| 4 | Roche Holding AG | 236 |
| 5 | Alnylam Pharmaceuticals Inc | 197 |
| 6 | Corteva Inc | 171 |
| 7 | The University of Texas System | 157 |
| 8 | Novartis AG | 150 |
| 9 | Thermo Fisher Scientific Inc | 140 |
| 10 | Centre National de la Recherche Scientifique | 120 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 7,133 |
| 2 | C12Q | Measuring/testing involving enzymes | 4,616 |
| 3 | A61K | Medicinal preparations | 4,508 |
| 4 | C07K | Peptides | 4,445 |
| 5 | A61P | Therapeutic activity (drug indications) | 4,169 |
| 6 | A01H | 2,284 | |
| 7 | G01N | Investigating / analysing materials | 2,272 |
| 8 | C12P | Fermentation, enzyme processes | 1,247 |
| 9 | C12Y | Enzyme nomenclature (EC numbers) | 1,159 |
| 10 | Y02A | Climate change adaptation | 1,087 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION | 2013 | University of California | 1,674 |
| Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme | 1990 | Roche Holding AG | 3,800 |
| Peptide nucleic acids | 1996 | 1,983 | |
| Strand displacement amplification | 1995 | Becton Dickinson and Co | 1,427 |
| Modifying plants by genetic engineering to combat or control insects | 1991 | Bayer AG | 1,490 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2019 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Nancy C. Stellwagen | University of Iowa | 3 |
| 2 | László Orbán | Agricultural Biotechnology Institute | 2 |
| 3 | Attila Zsolnai | Veszprémi Érseki Hittudományi Fõiskola | 2 |
| 4 | Jacek Szeliga | Nicolaus Copernicus University | 1 |
| 5 | Benjamin Chu | Stony Brook University | 1 |
| 6 | JO NORTHROP | University of Tennessee at Knoxville | 1 |
| 7 | N.M. Pettit | University of Tennessee at Knoxville | 1 |
| 8 | Mary K. Cowman | New York University | 1 |
| 9 | Dehai Liang | Stony Brook University | 1 |
| 10 | Daniele Gerion | Lawrence Livermore National Laboratory | 1 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionFrequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of TBE buffer?
How many patents mention TBE buffer and what is the recent patent activity trend?
Which companies hold the most patents related to TBE buffer applications?
What are the primary technical fields where TBE buffer patents are classified?
Who are the leading research authors publishing on TBE buffer?